Ipca Laboratories Limited (NSE:IPCALAB)
India · Delayed Price · Currency is INR 1,468.30
+6.90 (0.47%)
Apr 17, 2026, 3:30 PM IST
Ipca Laboratories Market Cap
Ipca Laboratories has a market cap or net worth of 372.51 billion as of April 17, 2026. Its market cap has increased by 1.49% in one year.
Market Cap
372.51B
Enterprise Value
387.14B
Revenue
95.06B
Ranking
n/a
PE Ratio
40.54
Stock Price
1,468.30
Market Cap Chart
Since June 12, 2002, Ipca Laboratories's market cap has increased from 3.22B to 372.51B, an increase of 11,473.25%. That is a compound annual growth rate of 22.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 372.51B | 3.48% |
| Dec 31, 2025 | 359.98B | -16.30% |
| Dec 31, 2024 | 430.08B | 52.29% |
| Dec 29, 2023 | 282.41B | 32.03% |
| Dec 30, 2022 | 213.90B | -22.18% |
| Dec 31, 2021 | 274.86B | -1.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurobindo Pharma | 805.28B |
| Alkem Laboratories | 667.41B |
| Glenmark Pharmaceuticals | 634.81B |
| Laurus Labs | 613.14B |
| Ajanta Pharma | 348.46B |
| Emcure Pharmaceuticals | 317.01B |
| Gland Pharma | 296.13B |
| Wockhardt | 226.73B |